Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists
Crossref DOI link: https://doi.org/10.1007/s11523-014-0333-x
Published Online: 2014-09-12
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rey, Jean-Baptiste
Launay-Vacher, Vincent
Tournigand, Christophe
License valid from 2014-09-12